Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

ENZ Stock Forecast, Price Targets, Chart, Dividends & Analysis

Enzo Biochem Inc. ($0.01 Par Value) logo

Enzo Biochem Inc. ($0.01 Par Value)

Sector: Healthcare   

Industry: Diagnostics & Research

0.31
 
USD
  
-0.07
  
(-17.77%)
Previous close: 0.3816  Open: 0.3702  Bid: 0.291  Ask: 0.4
52 week range    
0.25   
   1.27
Mkt Cap: 18 M  Avg Vol (90 Days): 332,863
Last updated: Monday 21st April 2025

Stock Rankings

54
MarketXLS Rank
80
Value
45
Technical
39
Quality
How are these ranks calculated?
Search for a stock

Metrics

Growth

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

ENZ Income Statement

Annual
Jul-15Jul-16Jul-17Jul-18Jul-19Jul-20Jul-21Jul-22Jul-23Jul-24
Amortization of intangibles-2 M-2 M-2 M-992000.07 M7 M7 M65 M
Basic EPS from continuing operations0.05-0.60.16-0.38-0.51-0.19
Basic EPS total-0.050.98-0.05-0.220.05-0.60.16-0.380.41-0.51
Basic weighted shares outstanding45 M46 M46 M47 M47 M47696.048 M48594.049160.050902.0
BasicDiscontinuousOperations0.92-0.32
CommissionExpenses150 M
Cost of sales-40 M-43 M-14 M-60 M58 M52 M64 M19 M18 M17 M
Depreciation2 M3 M3 M1 M
Depreciation unreconciled65 M
DepreciationAndAmortization2 M65 M3 M1 M
Diluted EPS total-0.050.97-0.05-0.220.05-0.60.16-0.380.41-1.02
Diluted normalized net income/share0.05-0.60.16-0.380.41-0.7
Diluted weighted shares outstanding45 M47 M46 M47 M47 M47696.048 M48594.049160.050902.0
DilutedDiscontinuousOperations0.92-0.32
GainOnSaleOfBusiness500000.0
GainOnSaleOfSecurity-1 M-1 M
GeneralAndAdministrativeExpense-5 M-5 M-5 M-4 M44 M43 M45 M23 M27 M22 M
Gross operating profit43 M46 M48 M41 M23 M24 M54 M13 M13 M15 M
Income before tax-2 M47 M-3 M-11 M2 M-29 M8 M-20 M-25 M-10 M
Income restructuring and M&A19 M
Income taxes-7000.01 M-1 M-1 M-94000.0-90000.0-305000.0-129000.0-22000.0-730000.0
Interest income-245000.0-136000.0384000.0853000.01 M8000.0159000.0277000.04 M
InterestExpenseNonOperating-1 M-454000.064 M-178000.01 M
InterestExpenseOperating-206000.0-121000.0-119000.0-76000.0524000.0-237000.0-231000.0-1 M-395000.0
MiscOtherSpecialCharges95000.0122000.0125000.0168000.0382000.0488000.07 M-1 M380000.0494000.0
Net income from total operations-2 M45 M-3 M-10 M2 M-29 M8 M-18 M20 M-26 M
NetIncomeCommonStockholders-2 M45 M-3 M-10 M-55 M-29 M8 M-18 M20 M-26 M
NetIncomeContinuousOperations-2 M45 M-3 M-10 M2 M-29 M8 M-20 M58 M-10 M
NetIncomeDiscontinuousOperations2 M-37 M-16 M
NetNonOperatingInterestIncomeExpense-245000.0-136000.0384000.0853000.01 M454000.0-64 M-178000.0277000.04 M
NonRecurringOperationExpense-3 M-51 M2 M5 M3 M7 M5 M5 M5 M3 M
Normalized income12 M-8 M
Operating income-4 M-4 M-1 M-7 M2 M-30 M692000.0-17 M-25 M-12 M
Operating income before depreciation (EBITDA)1 M50 M975000.0-8 M4 M-28 M3 M-9 M-21 M-9 M
OperatingExpense47 M49 M50 M48 M47 M47 M48 M26 M56 M44 M
Other income net-95000.0-122000.0-125000.0-168000.0-382000.0-488000.0-7 M-8 M-380000.0-494000.0
Other special charges-839000.0
OtherGainLossFromDispositionOfDiscontinuedOperations2 M-37 M-16 M
OtherGandA-5 M-5 M-5 M-4 M44 M43 M45 M23 M27 M22 M
OtherOperatingExpenses2 M2 M3 M4 M6 M6 M2 M11 M15 M
OtherWriteOff3 M605000.03 M5 M
PromotionAndAdvertising-556000.0-601000.0-649000.0-580000.0374000.0437000.0400000.0577000.0345000.0
RentAndLandingFees-5 M-5 M-5 M-4 M-134000.02 M2 M-2 M-2 M
Research & development expense3 M4 M3 M3 M3 M4 M3 M2 M4 M3 M
ResearchExpense3 M4 M3 M3 M3 M4 M3 M2 M4 M3 M
RestructringAndMnAIncome19 M
Revenue per share-2 M-2 M-2 M-992000.07 M8 M8 M65 M
SalariesAndWages-429000.0-525000.0-831000.0-813000.0939000.0923000.0907000.0500000.02 M2 M
Selling Gen & administrative expense41 M44 M44 M44 M44 M43 M45 M23 M27 M22 M
SellingAndMarketingExpense41 M44 M44 M44 M374000.0437000.0400000.0577000.0150 M
SellingExpense41 M44 M44 M44 M
Special income/charges3 M51 M-2 M-5 M-3 M-7 M-5 M-25 M-5 M-3 M
Total Income available for interest expense (EBIT)-2 M46 M-3 M-11 M1 M-30 M692000.0-12 M-24 M-11 M
Total common shares outstanding46 M46 M47 M47 M48 M48 M48 M49 M50 M
Total net income-2 M45 M-3 M-10 M2 M-29 M8 M-18 M20 M-26 M
Total ordinary shares52 M52 M52 M52 M52 M52 M52 M52 M52 M52 M
Total revenues98 M103 M108 M101 M81 M76 M118 M33 M31 M32 M
TotalExpenses7 M7 M36 M-13 M105 M100 M112 M45 M74 M62 M
TotalRevenue32 M30 M108 M101 M81 M76 M118 M33 M31 M32 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader